Cytokinetics CYTK
NASDAQ CYTK
$65.64 -0.52 (-0.79%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cytokinetics (CYTK) Restructuring Costs (2012)

Updated

Cytokinetics (CYTK) recorded Restructuring Costs of -$56,000 in FY2012, compared with $1.19 million in FY2011.

Analysis

Cytokinetics (CYTK) Restructuring Costs (2012) Analysis & Trends

  • Per Business Quant data, CYTK's Restructuring Costs was $1.19 million in FY2011 and -$23,000 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Cytokinetics 9.20 Bn 5.37 Bn 25.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 -2,000.00
Jun 30, 2012 -13,000.00
Mar 31, 2012 -41,000.00
API Access

Cytokinetics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=CYTK&period=max&api_key=YOUR_API_KEY